Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00230022 · ClinicalTrials.gov registry record · Phase 1

Pilot Clinical Trial of Computer-based Motivational Intervention - 1

A Phase 1 study of Substance-Related Disorders, sponsored by Wayne State University.

Completed
Registry status
Phase 1
Development phase
30
Enrollment target
1
Study location

NCT00230022: Completed Phase 1 study of Substance-Related Disorders, sponsored by Wayne State University.

NCT00230022 is a Phase 1 study of Substance-Related Disorders that has completed, run by Wayne State University. The registered enrollment target is 30 participants, below the 1,521-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00230022, a Phase 1 study of Substance-Related Disorders, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
Phase 1
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Pilot trial of computer-based motivational intervention. Hypothesis: The brief computer-delivered intervention would result in higher motivation to change at follow-up.

Primary Outcome

An eight-item measure tapping motivation to change, self-efficacy, and change intention was assessed using visual analog scales. The average of the eight items was calculated resulting in a score ranging from 1 to 100. The measure was asked at baseline (reported in baseline data) and the one month follow-up. Scores here represent average level of motivation for change at the time of follow-up. Higher scores represent higher levels of motivation to change, self-efficacy and intention to change.

Interventions

  • BEHAVIORAL Brief computer-delivered intervention

Study Locations (1)

Michigan

  • Wayne State University - Detroit

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2004-10
Est. Completion 2005-04
Phase Phase 1
Wayne State University

163 total trials

What the finished NCT00230022 record still lists

NCT00230022 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,521-participant average among 58 other Substance-Related Disorders trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Substance-Related Disorders appearing as the primary indexed condition, and to 1 intervention - of which Brief computer-delivered intervention is the first listed.

NCT00230022 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT00230022 about?

NCT00230022 is a clinical study titled "Pilot Clinical Trial of Computer-based Motivational Intervention - 1". Pilot trial of computer-based motivational intervention. Hypothesis: The brief computer-delivered intervention would result in higher motivation to change at follow-up.

What is the current status of trial NCT00230022?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2004-10. Estimated completion is 2005-04.

What conditions does trial NCT00230022 study?

This clinical trial studies the following conditions: Substance-Related Disorders.

What interventions are being tested in trial NCT00230022?

The interventions under investigation include: Brief computer-delivered intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT00230022?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00230022 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Substance-Related Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00230022's enrollment target sits among peer trials

30 53rd of 58 higher than 6 of 58 other Substance-Related Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Substance-Related Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00230022, the US trial registry maintained by the National Library of Medicine. NCT00230022 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.